Analysis of tumor development and progression demonstrated that mice with both the APC mutation and p16 epigenetic alteration exhibited significantly reduced survival times and enhanced tumor growth compared with mice harboring the APC mutation alone [53]. The gene discussed is CDKN2A; the disease is neoplasm.